Hikma Pharmaceuticals (HIKL)

1,238.50p
   
  • Change Today:
      0.25p
  • 52 Week High: 2,184.00
  • 52 Week Low: 1,202.00
  • Currency: UK Pounds
  • Shares Issued: 199.39m
  • Volume: 170,585
  • Market Cap: £2,469.38m

Financial Analysis

Select chart: EPS | Revenue

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 2,553.00 544.00 194.80¢ 15.1 1.2 +13% 54.00¢ 1.8%
31-Dec-22 2,517.00 233.00 181.00¢ 11.4 n/a -7% 56.00¢ 2.7%
31-Dec-23 2,875.00 281.00 223.00¢ 10.6 0.5 +23% 72.00¢ 3.1%
31-Dec-24 3,127.00 455.00 224.00¢ 11.9 n/a 0% 80.00¢ 3.0%
31-Dec-25 3,349.00 519.00 228.00¢ 9.1 4.5 +2% 84.00¢ 4.1%

Forecasts

Forecasts data is not available for this company.

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 19.91 10.14 13.39 0.58

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

HIKL Market Data

Currency UK Pounds
Share Price 1,238.50p
Change Today 0.25p
% Change 2.02 %
52 Week High 2,184.00
52 Week Low 1,202.00
Volume 170,585
Shares Issued 199.39m
Market Cap £2,469.38m

Trades for 13-Mar-2026

Time Volume / Share Price
16:29 358 @ 1,238.50p
16:29 399 @ 1,238.50p
16:29 393 @ 1,238.50p
16:29 85 @ 1,238.50p
16:29 85 @ 1,238.50p

HIKL Key Personnel

CFO Khalid Nabilsi

Top of Page